Adaptimmune Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by State Street Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $381k | 391k | 0.97 |
| 2024-03-31 | $494k | 313k | 1.58 |
| 2023-12-31 | $242k | 305k | 0.79 |
| 2023-09-30 | $233k | 299k | 0.78 |
| 2023-06-30 | $269k | 291k | 0.93 |
| 2023-03-31 | $310k | 285k | 1.09 |
| 2022-12-31 | $392k | 269k | 1.46 |
| 2022-09-30 | $332k | 309k | 1.07 |
| 2022-06-30 | $623k | 367k | 1.70 |
| 2022-03-31 | $1.3M | 641k | 2.06 |
| 2021-12-31 | $2.3M | 615k | 3.75 |
| 2021-09-30 | $2.9M | 567k | 5.19 |
| 2021-06-30 | $1.1M | 260k | 4.26 |
| 2021-03-31 | $2.2M | 408k | 5.31 |
| 2020-12-31 | $1.9M | 361k | 5.39 |
| 2020-09-30 | $1.6M | 206k | 7.98 |
| 2020-06-30 | $1.7M | 172k | 10.01 |
| 2019-03-31 | $170k | 40k | 4.31 |
| 2018-12-31 | $234k | 41k | 5.76 |
| 2018-09-30 | $492k | 36k | 13.56 |
| 2018-06-30 | $431k | 36k | 11.88 |
| 2018-03-31 | $424k | 38k | 11.23 |
| 2017-12-31 | $678k | 101k | 6.69 |
| 2017-09-30 | $837k | 102k | 8.19 |
| 2017-06-30 | $295k | 66k | 4.48 |
| 2017-03-31 | $363k | 66k | 5.52 |
| 2016-12-31 | $266k | 66k | 4.04 |
| 2016-09-30 | $464k | 66k | 7.05 |
| 2016-06-30 | $536k | 66k | 8.15 |
| 2016-03-31 | $535k | 66k | 8.13 |
| 2015-12-31 | $794k | 66k | 12.07 |